#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal adenocarcinoma stage III Neuromyelitis optica spectrum disorder Cutaneous calcification Malignant melanoma Neuropathy peripheral Osteopetrosis Indolent systemic mastocytosis Primary hyperoxaluria Waldenstrom's macroglobulinaemia refractory Philadelphia positive chronic myeloid leukaemia Cystic fibrosis lung Brain abscess Antiphospholipid antibodies Mantle cell lymphoma stage IV Bulbospinal muscular atrophy congenital More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Life with Disease Pleomorphic leiomyosarcoma – Diagnostics Systemic sclerosis pulmonary – Diagnostics Pemphigoid Breast angiosarcoma metastatic – Diagnostics Hereditary optic atrophy Richter’s syndrome – Treatment Ewing’s sarcoma metastatic – Basic Information Hereditary optic atrophy – Diagnostics Glycogen storage disease type I – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Duvakitug Doxazosin Mesilate CITRIC ACID ANHYDROUS Bisoprolol Tolvaptan Nvl-655 Pehero Clavulanic Acid Thalidomide Flutafuranol (18F) Bay 3283142 ZIGAKIBART Sacubitril TRONTINEMAB Ofatumumab Azd8630 Metoprolol Tartrate Transpocart19 Filgrastim Caplacizumab More therapies…

    Learn about Your Condition

    Uterine leiomyosarcoma Parkinson's disease Neuroblastoma recurrent Binge eating Von Willebrand's disease Phenylketonuria Asthmatic crisis Blood iron increased Angiosarcoma metastatic Neuroblastoma Gout Stem cell transplant Limb reduction defect Still's disease Respiratory failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on ABBV-400, Fluorouracil, Leucovorin, and Budigalimab for Advanced or Metastatic Stomach and Esophageal Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Budigalimab
    • Fluorouracil
    • Folinic Acid
    Belgium Germany Spain

  • Study of SAR441566 compared to placebo for adults with moderate to severe Crohn’s disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    Bulgaria Croatia Czechia France Germany Hungary +5

  • Study on Improving Bowel Function in Patients with Low Anterior Resection Syndrome Using Glycerol Suppositories or Transanal Irrigation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Low anterior resection syndrome
    Investigated Drugs:
    • Glycerol
    Denmark

  • Study on Treating Stomach Cancer with Peritoneal Spread Using Docetaxel and Oxaliplatin in Patients with Limited Peritoneal Carcinomatosis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Docetaxel
    • Oxaliplatin
    Denmark Finland The Netherlands Sweden

  • Study on the Effectiveness of Budesonide and Omeprazole for Treating Crohn’s Disease in the Esophagus, Stomach, or Duodenum in Children

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Omeprazole
    • Budesonide
    Poland

  • Study on the Effect of Pancreatic Enzyme Replacement Therapy with Pancreas Powder in Patients with Pancreatic Exocrine Insufficiency After Total Gastrectomy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic failure
    Investigated Drugs:
    • Pancreas Powder
    Poland Portugal Spain
Previous Page
1 … 62 63 64 65 66 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!